Department of Gastric Surgery, Sun Yat-sen University Cancer Center, No.651 Dongfeng Road East, Guangzhou, 510060, Guangdong, China.
BMC Cancer. 2021 Feb 23;21(1):188. doi: 10.1186/s12885-021-07904-7.
Gastric outlet obstruction (GOO) is a late complication of advanced gastric cancer, and it is controversial how to select the therapeutic strategies: gastrojejunostomy and palliative gastrectomy? Therefore, this study was to compare the surgical and survival outcomes of gastrojejunostomy and palliative gastrectomy.
In total, 199 gastric cancer patients with outlet obstruction treated by surgery between January 2000 and December 2015 at Sun Yat-sen University Cancer Center were retrospectively reviewed. Patients were divided into gastrojejunostomy group and palliative gastrectomy group. Propensity score matching (PSM) was performed to balance the selection bias.
After 1:1 PSM, a total of 104 patients were included for final analysis. The median overall survival (OS) times in the gastrojejunostomy group and palliative gastrectomy group were 8.50 and 11.87 months, respectively (P = 0.243). The postoperative complication rates in the gastrojejunostomy group and palliative gastrectomy group were 19.23% (10/52) and 17.31% (9/52), respectively (P = 0.800), and no treatment-related death was observed. Multivariate analysis showed that periton0eal seeding (P = 0.014) and chemotherapy (P < 0.001) were independent prognostic factors. Among them, peritoneal seeding was a risk factor and postoperative chemotherapy was a protective factor.
Our results indicated that although the surgical complications of palliative gastrectomy were manageable, it showed no survival benefit. Therefore, relieving obstruction symptom, improving patients' quality of life and creating better conditions for chemotherapy appear to be the main therapeutic strategies for advanced gastric cancer with GOO.
胃出口梗阻(GOO)是晚期胃癌的晚期并发症,对于如何选择治疗策略(胃空肠吻合术和姑息性胃切除术)存在争议。因此,本研究旨在比较胃空肠吻合术和姑息性胃切除术的手术和生存结果。
回顾性分析中山大学肿瘤防治中心 2000 年 1 月至 2015 年 12 月期间接受手术治疗的 199 例胃癌伴出口梗阻患者的临床资料。患者分为胃空肠吻合术组和姑息性胃切除术组。采用倾向评分匹配(PSM)平衡选择偏倚。
经 1:1 PSM 后,共有 104 例患者纳入最终分析。胃空肠吻合术组和姑息性胃切除术组的中位总生存期(OS)分别为 8.50 和 11.87 个月(P=0.243)。胃空肠吻合术组和姑息性胃切除术组的术后并发症发生率分别为 19.23%(10/52)和 17.31%(9/52)(P=0.800),无治疗相关死亡。多因素分析显示,腹膜播种(P=0.014)和化疗(P<0.001)是独立的预后因素。其中,腹膜播种是危险因素,术后化疗是保护因素。
本研究结果表明,尽管姑息性胃切除术的手术并发症可以控制,但并未显示出生存获益。因此,缓解梗阻症状、提高患者生活质量并为化疗创造更好的条件,似乎是治疗晚期胃癌伴 GOO 的主要治疗策略。